Neuroscience grants

Postdoctoral fellowship program in collaboration with the Japan Society for the Promotion of Science (JSPS). Supports Swiss early-career researchers for research stays in Japan. Mobility/residency rules likely apply.

Online certified education programme open to Master students, Master graduates, PhD students, and healthcare professionals in healthcare-related studies. Covers health data analytics, AI, FAIR principles, GDPR, EHDS, telemedicine, and precision medicine. Costs vary: EU students €1,000, non-EU students €2,000, EU professionals €2,000, non-EU professionals €4,000. Professional English required.

Online education programme open to Master's and PhD students and working/healthcare professionals seeking to upskill in digital medical devices. Covers AI, cybersecurity, MDR/IVDR regulation, and personalised health solutions. Costs vary by applicant type (EU student €1,000 to non-EU professional €4,000 excl. VAT); professional English required.

EIT Label-certified online education programme (up to 30 ECTS) open to Master students/graduates, PhD students, and healthcare professionals in healthcare-related fields. Professional English required. Costs vary: EU students €1,000, non-EU students €2,000, EU professionals €2,000, non-EU professionals €4,000 (excl. VAT). Focuses on high value care, innovation, entrepreneurship, and leadership in healthcare.

BRIDGE Discovery is a joint funding scheme by SNSF and Innosuisse supporting projects that bridge fundamental research and innovation/application. Open to researchers at Swiss institutions.

Full proposal stage (by invitation only) for the Crazy 8 Brain Tumor grant targeting pediatric brain tumor research. Open since January 2026; notification in November 2026.

PPP call for projects strengthening Pb-212 production/supply chain or enabling technologies for clinical application of Pb-212-based radiopharmaceuticals. Proposals must involve public-private collaboration and be submitted through KWF GMS; projects are embedded in a national TRT innovation network. Clinical trials and full therapeutic product development are out of scope.

PPP call for projects strengthening Pb-212 production/supply chain or enabling technologies for clinical application of Pb-212-based radiopharmaceuticals. Proposals must involve public-private collaboration with 40–60% industry co-funding, be submitted through KWF GMS, and align with Lead4Life governance and national TRT network. Clinical trials and full therapeutic product development are out of scope.

Open only to consortia focused on further development and validation of existing non-animal (NAM) methods for chemical safety assessment. Main applicant must have participated in both collaborative workshops (14 Jan & 4 Feb 2026). Consortium must be knowledge chain-wide and interdisciplinary; may include humanities/social sciences, exact sciences, legal experts, civil society, and industry. Proposals submitted via MijnZonMw only. Funds a single project.

Health research funding for cancer-relevant projects submitted via Kreftforeningen as applicant organisation. Supports research promoting living conditions, health, coping, quality of life, or social participation in Norway. Max 7 applications via Kreftforeningen. User involvement required. Proposals in Norwegian via Damnett portal.

Supports investigator-initiated clinical trials. Applicants must be based at Swiss research institutions. Clinical trial focus with patient-sample needs expected.

Funding for researcher projects in cancer research across thematic areas including free cancer research, breast cancer (Rosa sløyfe from 2025 campaign), genomic testing, young promising cancer researchers, and geographic distribution. Norwegian institutions. Proposals via SøknadsWeb.

Main Applicant must be from a Steno Diabetes Center or a Steno Partner Institution (hospitals with a cooperative agreement with a Steno Diabetes Center) in Denmark. Project must include 2–5 co-applicants. Focuses on clinical, patient-centered, and collaborative diabetes research. International co-applicants eligible; international collaboration encouraged.

Green Platform call supporting green innovation and transition. Open to Norwegian applicants. Proposals must be submitted in Norwegian or as specified in the call text. Full call text may still be in temporary/draft form; check the official page for final requirements.

Open to experienced independent researchers (not PhD students or postdocs) at universities, hospitals, or non-profit research institutions in Denmark, Finland, Iceland, Norway, or Sweden. Covers basic and clinical research in endocrinology and metabolism. Co-applicants not allowed; applicant's own salary cannot be covered. DKK 11M earmarked for special theme 'Hormone regulation in women's health'.

Master's scholarships (Mathematics, Physics, Chemistry, Biology) for nationals of PALOP countries (Angola, Cabo Verde, Guiné-Bissau, Moçambique, São Tomé e Príncipe) residing in their home country, aged ≤30, with a degree GPA ≥14/20 from a home-country university. Study must be in-person at a Portuguese higher education institution. Application form must be submitted in Portuguese. Cannot be combined with other scholarships.

Childhood cancer bio-therapeutic research grant from Alex's Lemonade Stand Foundation. Opened April 2026; notification November 2026. Scope and eligibility details available on the applicants page.

Certification as an established researcher (R3) under the Spanish R&D system. Applicants must hold a doctorate obtained before 1 January 2021, have at least 2–5 years of postdoctoral contractual experience, and have completed ≥2 years of research stays at institutions other than their doctoral host. Excludes permanent civil-servant academic staff and those already holding R3/I3 certification. Proposals must be submitted in Spanish.

Accelerator-track childhood cancer research grant from Alex's Lemonade Stand Foundation. Opened March 2026; notification October 2026. Scope and eligibility details available on the applicants page.

Childhood cancer research grant from Alex's Lemonade Stand Foundation. Opened March 2026; notification November 2026. Scope and eligibility details available on the applicants page.

First call under the One Health Antimicrobial Resistance (OHAMR) international partnership. Focuses on combating antimicrobial resistance through a One Health approach (human, animal, environmental health). Transnational consortia required.

Collaborative research projects between Swiss and Australian institutions on AI in healthcare for underrepresented populations (sex, gender, sexual orientation). Swiss applicants must be based at a Swiss research institution; SNSF funds the Swiss side (max CHF 400k/project), NHMRC funds the Australian side. Up to 10 projects funded. Proposals must be submitted to both agencies.

Late-phase (phase 2/3) international clinical trials on radiotherapy or surgery for rare cancers (incidence <6/100,000/yr) and/or hard-to-treat cancers (5-yr survival <25%). Consortium must include partners from ≥3 of 5 funding countries (BE, NL, ES, NO, SE). Five projects invited to full proposal phase; submission via Swedish Cancer Society's Grant Application System.

Interdisciplinary fundamental research involving at least two of the three FRQ sectors (Health / Society & Culture / Nature & Technologies), carried out at an eligible Flemish host institution in collaboration with Québec partners. Staff & consumables: min €45k–max €85k/year; equipment: max €150k/project. Applicant may act only once as supervisor(-spokesperson) or co-supervisor per call. Proposals submitted in English or French via FWO E-portal.

Joint NL–Brazil (São Paulo/FAPESP) research on replacing fossil raw materials with circular biomass-derived materials. Topics: biobased feedstocks and conversion processes. Requires multidisciplinary consortium including a private co-funder; NWO/FAPESP finance max 70%, mandatory 30% co-funding required. Small-scale (€140k–€290k) or large-scale (€350k–€700k) project sizes available.

Joint NL–Brazil (São Paulo/FAPESP) research call on replacing fossil raw materials with circular biomass-derived feedstocks. Two project sizes: small-scale (€140k–€290k) and large-scale (€350k–€700k); NWO/FAPESP fund max 70%, mandatory 30% co-funding from industry. Topics: biobased feedstocks and conversion processes; multidisciplinary scope required (chemical engineering, economics, sustainability, social, legal).

Open to Spanish public research centres and non-profit private research institutions with internationally recognised scientific leadership. Two tracks: 'Centro de Excelencia Severo Ochoa' (research centres with legal personality and administrative autonomy) and 'Unidad de Excelencia María de Maeztu' (research units). Includes associated funding for predoctoral researcher training. Proposals must be submitted in Spanish via AEI application portal.

Funds research projects linked to ERC proposals (Starting, Consolidator, Advanced Grants) that were positively evaluated and deemed eligible by the ERC but not funded due to budget constraints. Applicants must be public or private non-profit research/knowledge-dissemination organisations based in Spain. Covers personnel costs, minor equipment, materials, and related project expenses. Proposals must be submitted in Spanish.

Open to French or foreign researchers affiliated with a French public research institution who were ranked 'A' (but unfunded) in the ERC Advanced Grants 2025 call. Aims to help improve proposals for resubmission to ERC Consolidator or Advanced Grant. All scientific disciplines eligible. Proposals likely in French; simplified dossier based on prior ERC application documents.

Call for proposals under the BrainHealth Partnership focusing on brain health research. Open to researchers affiliated with Swiss institutions applying through SNSF.

Call under the Swiss Transplant Cohort Study (THCS) or related health cohort scheme focusing on access to care. Supports research addressing healthcare access challenges within the Swiss context.

Thematic multilateral call on neurodegenerative disorders under the EP BrainHealth partnership. Budget cap per call and/or proposal applies. Luxembourg partner must submit INTER application at both pre-proposal and full proposal stage via FNR online system. Thematic call — no bottom-up funding.

For mid-career researchers ready to lead a substantial research programme. Administering organisation must be in the UK, Republic of Ireland, or a low/middle-income country (excluding India and mainland China); must be a not-for-profit HEI, research institute, or healthcare organisation. Applicant must contribute at least 80% research time; health professionals must be registered with relevant regulator.

Funds creation and development of Spanish research networks (Redes Temáticas, Redes ICTS, Redes Estratégicas, Redes para Planes Complementarios) to foster collaboration and synergies among research groups. Eligible applicants: universities, public R&D centres, technology centres, and non-profit entities linked to science/technology. Proposals must be submitted in Spanish. Part of Plan Estatal 2024-2027.

Open to consortia of Luxembourg-based private companies and public research institutions. Covers R&D in data analytics/HPC, AI (ML, computer vision, NLP, edge AI), and quantum technologies. Projects must be industrial research and/or experimental development. SMEs leading a project may receive 30% upfront payment. Self-funded international partners may participate. Proposals submitted via research-industry-collaboration.lu platform.

For senior researchers (PhD + 10 years minimum) affiliated to a Belgian university, university hospital, or eligible research institute until 31 Dec 2030. Funds rare disease research (bench to bedside); rare cancers and rare adverse drug events excluded. Proposals must be submitted in English. Up to 30% may be outsourced internationally or to the private sector.

Bilateral Weave/Lead Agency call between SNSF and F.R.S.-FNRS (Belgium, Wallonia-Brussels). Swiss applicants apply under SNSF project funding; Belgian applicants must be based at one of six eligible universities (UCLouvain, ULB, ULiège, UMons, UNamur, USL-B). Max 2 simultaneous SNSF project grants allowed. Proposals in languages other than English (possible in some humanities/social sciences disciplines) require prior agreement with all agencies.

Funds academic-led clinical trials (Phase I–III) for new investigational medicinal products in oncology addressing unmet medical needs. Lead institute must be a medical centre or research institute in the Netherlands; public participating parties must be in Europe. Patient involvement is mandatory. Phase I/I-II budget: €1–2.5M; Phase II/III: €1–5M. Proposals must be in English. Public-private partnerships allowed; repurposing of registered drugs is out of scope.

Open to healthcare institutions, educational institutions, and non-profit organizations operating on Aruba, Bonaire, Curaçao, Sint Maarten, Statia, or Saba. Lead applicant must be based on one of the ABCSSS islands. At least 75% of budget must be spent locally on the islands. Proposals must be written in English. Co-financing encouraged but not mandatory.

Open to Dutch knowledge institutions, societal organisations and citizens. Consortium required (main applicant + co-applicant + cooperation partner). Phase 1 selects up to 4 pre-proposals; Phase 2 merges them into a single joint application via NWO-facilitated synergy workshops. Focuses on mechanisms of drug(-related) harm and effective societal interventions. Submissions via Mijn ZonMw only.

Second funding phase of GroenvermogenNL WP2 focusing on liquid hydrogen import/transport/storage, hydrogen carrier conversion, and port infrastructure. NWO funds 51–80% of project costs; minimum 20% co-funding required from private parties or own contributions. Consortium must include organisations with demonstrable R&D activities in the Netherlands. Proposals must be submitted in English via ISAAC.

Bilateral Flemish–French-speaking Belgium (FNRS) fundamental research project under the Weave Lead Agency Principle. Flemish supervisor-spokesperson must be eligible under FWO junior/senior project regulations (Article 7, 10–12). Proposals submitted in full to FNRS as Lead; Flemish side submits administrative form to FWO E-portal. Counts toward FWO's maximum of one active research project per applicant per round.

Bilateral Flemish–French-speaking Belgian collaborative fundamental research project under the Weave Lead Agency Principle. Flemish supervisor-spokesperson must be eligible under FWO junior/senior research project regulations. Flemish institutions must comply with FWO Article 7 conditions. Proposals submitted to FNRS as Lead Agency; FWO administrative submission via E-portal using form 'Research project WEAVE (FWO acts as Partner Agency)' within 7 days of FNRS deadline.

Open to UK research groups and individuals at any career stage (NERC eligibility applies). Must include at least one new international project partner (any country). NERC funds 80% FEC up to £100k; international partner travel/subsistence up to £15k at 100% FEC. Joint applications with São Paulo (FAPESP) or Taiwan (NSTC) partners eligible for co-funding. No PhD studentship costs or equipment ≥£25k. Projects must start by 1 February 2027.

For early-career researchers (PhD passed + ≤3 years postdoc) at not-for-profit institutions in UK, Republic of Ireland, or eligible LMICs (excl. India and mainland China). Must contribute ≥80% research time. No co-applicants accepted. Funds salary plus up to £400k research expenses. Health professionals must hold relevant professional registration.

Invite-only call for UK university-led clusters bringing together academia, industry, and regional partners to drive R&D and growth in the creative industries. Proposals must address regional/national impact, include EDI framework, sustainability plan, and governance plan. Project partners (industry, academia, third sector, government, UK or overseas) are encouraged. No institutional matched funding requirement beyond standard 20% FEC.

For early-career independent investigators (lab established 3–8 years prior to Dec 31, 2026; i.e., 2018–2023). Open worldwide to non-profit academic/research institutions. Single PI only; no co-investigators. Applicants must have multi-year independent funding active in 2027. Proposals must be in English and distinct from the applicant's main research portfolio. Indirect costs capped at 10% of direct costs.

Curiosity-driven basic research in earth sciences, astronomy, chemistry, computer science, life sciences, physics or mathematics. Single main applicant with tenured or tenure-track position at eligible Dutch research organisation. Proposals must be in English. One submission per applicant per 12 months. ENW-M-1: single scientific position, max €400k.

International collaboration grant: Dutch main applicant (tenured/tenure-track at eligible NL institution) with co-applicant(s) from Germany/Luxembourg/Flanders. NWO acts as lead agency. Proposals in English. Covers a single temporary scientific position. Partner agencies: DFG, FNR, FWO.

Dutch co-applicant submits administrative submission to NWO as partner agency for a Weave bilateral proposal led by DFG. Eligible applicants: full/associate/assistant professors or equivalent with tenured or tenure-track position at eligible Dutch institutions. Max one Dutch applicant; max €400k for one PhD or postdoc position plus other budget modules. Proposals must be in English. One ENW-M submission per 12 months rule applies.

Postdoctoral mobility fellowship for researchers with Swiss ties (Swiss nationals, C-permit holders, or PhD/state exam at Swiss HEI). Must apply within 3 years of PhD defence (or 8 years post-state exam for MDs). Requires a research stay abroad; return to institution of education not permitted. Part-time (min. 0.8 FTE) allowed for return grant phase with family care duties.

Interdisciplinary body-brain interaction research bridging neuroscience and cardiometabolic fields. 2–3 applicants required; at least one anchored at a Danish non-commercial institution and one at a non-Danish European non-commercial institution. Applicants must be independent researchers. No commercial activities, drug trials with industry, or overhead costs funded. Proposals must be submitted in English via the Lundbeck Foundation's LANAS system.

Organisation applicants only. Supports scientific journals within humanities and social sciences. Open 6 May – 18 August 2026.

Supports larger investigator-initiated clinical trials in Denmark with no commercial purpose, aimed at improving patient treatment through new medicine and technology. Open to established and mid-career research leaders (Associate Professor / Professor level). Host institution must be based in Denmark.

Research grants for 1–3 years for scientific cancer research in Finland; longer periods prioritised. Also available to newly established research groups whose leader has completed a successful postdoctoral period. No grants to tobacco-industry-funded researchers.

Open to non-profit organisations and public institutions in Denmark, Greenland, and the Faroe Islands. Research institutions may be co-applicants but not lead applicants. Projects must integrate health promotion into social initiatives for vulnerable children aged 0–10. Cross-sectoral collaboration between health and social sectors required. Proposals in Danish or English; Greenlandic/Faroese not accepted. Project start between 1 Jan–31 Dec 2027.

Open to research leaders (junior, mid-career, and established/professor level) at institutions in the Nordic countries. Covers industrial and environmental biotechnology research. Budget up to DKK 4.3 million per grant. Proposals submitted via the NNF Norma portal.

Postdoctoral fellowships for research in industrial and environmental biotechnology. Host institution must be in a Nordic country (including Denmark). Open to PhD students and postdoctoral researchers. Proposals submitted via the NNF Norma portal.

Bilateral Swiss–South African collaborative projects under SNSF Project Funding / Weave Lead Agency scheme. South African partner must be affiliated with a recognised public higher education or research institution in South Africa. Proposals must be submitted in English. Max 2 simultaneous SNSF project grants per applicant; topics must be clearly distinct. Projects start on the same date in both countries.

DFG funding for Ukrainian researchers as part of expanded refugee researcher support. Covers living expenses up to €1,000/month per Ukrainian project leader and allows supplemental proposals to include Ukrainian partners in existing German or German-Ukrainian projects. Requires confirmation from Ukrainian university of limited or no salary payment. Open to proposals received up to 31 August 2026.

DFG funds the Ukrainian share of bilateral German-Ukrainian research projects under Cooperation with Developing Countries. German applicants can request up to €1,000/month per Ukrainian project leader for living expenses. Supplemental proposals possible for existing projects. Initiation of International Collaboration instrument also available.

Funds fundamental (Basic) and Credentialing cancer research, including biological mechanisms of cancer onset/progression and psychosocial impacts. Open to Research Project, Consortium, and Unique High-Risk proposal types. Participating institutes must be registered in KWF GMS at least 6 weeks before closing. YIG proposals must be submitted under the separate 2026/YIG call.

Dedicated to basic research uncovering mechanisms driving cancer onset, growth, and spread. Intended for proposals within the Basic research and Credentialing phases. Aims to address knowledge gaps and identify new leads for prevention, diagnosis, and treatment.

Open to early-career scientists worldwide (<5 years mentored research post-PhD at award activation) at non-profit institutions. Supports dual training in cancer immunology and computational biology/data science. No citizenship restrictions. Must be conducted under a sponsor holding assistant professor or higher rank. Proposals must be hypothesis-driven in basic or translational cancer immunology.

Funds fundamental (Basic Research phase 1) and Credentialing (phase 2) cancer research, including biological mechanisms of cancer onset/progression and psychosocial impacts. Proposal types: Research Project, Consortium, and Unique High-Risk. Submitted via KWF GMS; participating institutes must register ≥6 weeks before closing. YIG proposals must use the separate 2026/YIG call.

For registered healthcare professionals (including doctors, nurses, AHPs, vets) who hold a PhD received ≥5 years ago and wish to reacquire research skills. Fellowship must be hosted at an eligible UK research organisation; international applicants must hold or obtain UK regulatory body registration. Funded at 80% FEC. Jointly funded options available with named charities. Applicant must intend to be clinically active in the UK during or after the award.

Open to registered healthcare professionals (doctors, nurses, vets, etc.) of any nationality, but fellowship must be hosted at an eligible UK research organisation. Applicants must hold a completed PhD or equivalent (before award start). Must not have previously secured independence via grants leading research staff. Fellowship must be based full-time at host; clinical sessions up to 4/week permitted for relevant specialties. Joint funding available with several charities (e.g. Diabetes UK, Parkinson's UK).

Supports STEM education, science pedagogy research, and informal science/technology learning for children, youth, and the general public in the Danish realm. Administering institution must be a public institution or non-profit org (incl. schools, municipalities, research institutions, museums, associations) in Denmark. Proposals in Danish or English. Research projects must be anchored at a Danish university or university college.

Supports projects innovating, implementing and/or scaling up sustainable behaviour and practices among individuals, communities, and organisations in Denmark. Host institution must be based in Denmark. Up to DKK 6M for projects up to 3 years.

Project grants (DKK 100k–6.6M) to strengthen STEM teaching quality in Danish vocational and professional education (EUD/EUX, erhvervsakademi, professionsbachelor) within sustainability and health. Administering institution must be a public or non-profit organisation in the Danish realm (Denmark, Greenland, Faroe Islands). Proposals in Danish or English. Pure research projects and research fellowships are excluded.

For senior researchers at the consolidation/leadership stage who obtained their PhD within 15 years before 1 March 2026 (extensions possible). Applicants must demonstrate that Vici will substantially contribute to consolidating their research group. Proposals must be written in English. Hosted at Dutch knowledge institutions via ZonMw/NWO.

Funds clinical research (Proof of Concept or Clinical Validation studies) into drug repurposing of existing off-patent medicines for ME/CFS patients in the Netherlands. Applicants must be Dutch legal entities (public or private law). Non-research organisations must provide ≥50% co-financing. Proposals must be submitted in English via My ZonMw.

Open to UK research groups and individuals (any career stage, subject to NERC eligibility). Focuses on aviation non-CO2 climate impacts across three themes: contrail/aerosol prediction confidence, future fuels (SAF, hydrogen, fuel cells), and decision-making support. Projects with industrial partnerships encouraged. Up to 6 projects funded; projects must start no later than 1 February 2027. UK host institution required.

Open to postdoctoral researchers of any nationality with max 8 years post-PhD experience. European Fellowships require a host in an EU/associated country; Global Fellowships require EU/associated country nationals or long-term residents working in a third country then returning to Europe. Researchers must not have resided in the host country for more than 12 months in the last 3 years (standard MSCA mobility rule). Open to all scientific fields including Euratom research.

Global Fellowships for nationals or long-term residents of EU Member States or Associated Countries, involving an outgoing phase at a non-EU/Associated Country partner and a mandatory return phase. Researchers must hold a PhD and have ≤8 years full-time research experience. MSCA mobility rules apply to both outgoing and return phases. Full-time commitment required as a rule.

Global Fellowships for nationals or long-term residents of EU Member States or Associated Countries, involving an outgoing phase at a non-EU/Associated Country host and a mandatory return phase. Researchers must have a PhD and ≤8 years full-time research experience at deadline. Mobility rule applies. Full-time employment required as a rule.

Restricted to nationals or long-term residents of EU Member States or Horizon Europe Associated Countries, max 8 years post-PhD. Outgoing phase at a non-EU/non-Associated Country organisation, with mandatory return phase to an EU/Associated Country host. Full-time commitment required; mobility rules apply.

Open to PhD holders of any nationality. European Fellowships: mobility to/within EU Member States or Horizon Europe Associated Countries. Global Fellowships: EU nationals or long-term residents, outgoing phase in non-associated Third Country + mandatory 12-month return phase to EU/Associated Country host. Applications submitted jointly by researcher and academic or non-academic host organisation. Specific Euratom conditions apply for nuclear research areas.

Open to postdoctoral researchers of any nationality with max 8 years post-PhD experience. European Fellowships: host in EU/Horizon Europe associated country. Global Fellowships: EU/associated country nationals or long-term residents, outgoing to third country then returning to Europe. Host organisations can be universities, research institutions, companies, SMEs, hospitals, NGOs, or public bodies. ERA Fellowship opt-in available for widening-country hosts.

Open to PhD holders of any nationality. European Fellowships: any nationality, hosted in EU/Associated Country. Global Fellowships: European nationals or long-term residents, outgoing phase at a non-associated Third Country (e.g. Canada) + mandatory 12-month return phase to EU/Associated Country host. Supports international, interdisciplinary, and inter-sectoral mobility including non-academic sector, reintegration, displaced researchers, and career-restart cases.

Horizon Europe RIA under the EU Cancer Mission supporting development of validated microbiome tools for early cancer prediction before disease onset, including AI risk modelling, longitudinal cohort studies, and comparison with liquid biopsy tests. Proposals must address multiple cancer types where possible and collaborate with large cohorts/registries. Lump sum grant; one grant expected.

Allocates national HPC, AI, and Scientific Cloud Computing resources (Deucalion, Cirrus+Stratus, MareNostrum 5). A0: experimental access (6 months, up to 50,000 CPU core.hours / 500 GPU.hours); A1: development access (3–12 months, up to 100,000 CPU core.hours / 5,000 GPU.hours). Eligible: Portuguese R&D institutions, collaborative labs, tech-interface centres, digital innovation hubs, non-profits, and companies/individuals active in Portugal. Applications must be submitted in English via myFCT platform.

Advanced computing access (HPC, AI, Cloud) for teams with no prior RNCA experience. Proposals must be submitted in English via myFCT. Max 50,000 CPU core-hours and 500 GPU-hours per project. Eligible applicants include R&D institutions, companies (pre-competitive R&D only), and individuals active in Portugal. Fast-track (via rápida) requires prior scientific evaluation in the last 3 years.

Horizon Europe RIA under the Cancer Mission calling for development of advanced multiscale Virtual Human Twin (VHT) models integrating AI and multimodal patient data to understand cancer onset/progression and personalise treatments. Proposals must include multidisciplinary consortia (medical, AI, patient representatives, SMEs) and share data/models via UNCAN.eu and the Advanced VHT Platform under open science principles. Clinical studies may be included with a dedicated annex.

Horizon Europe RIA (lump sum) for academic investigator-initiated pragmatic clinical trials on immunotherapeutic interventions for refractory cancer patients. Proposals must include a clinical studies annex, disaggregate data by sex/gender/age, and engage patients in endpoint definition. Applicants must include diverse stakeholders and plan to join the EU Cancer Mission 'Diagnosis and Treatment' cluster. ~3 grants expected.

Horizon Europe RIA under the Cancer Mission. Requires development of multiscale AI-integrated Virtual Human Twins for cancer onset, progression and personalised treatment. Proposals must include clinical study annex if clinical studies are envisaged. Interdisciplinary consortia including healthcare professionals, patient representatives, AI experts and SMEs expected. Open science principles mandatory; data must be shared via UNCAN.eu and Advanced VHT Platform.

Allocates national HPC, AI, and Scientific Cloud Computing resources (Deucalion, Cirrus+Stratus, MareNostrum 5). A0 = Experimental Access (6 months, max 50,000 CPU core.hours / 500 GPU.hours); A1 = Development Access (3–12 months, max 100,000 CPU core.hours / 5,000 GPU.hours). Eligible: Portuguese R&D institutions, collaborative labs, tech-interface centres, companies (pre-competitive R&D only, ≤50% of total quota), and individuals active in Portugal. Applications must be submitted in English via myFCT platform.

Supports novel, ambitious, transformative arts and humanities research teams (3–5 years, £2M–£3M FEC; AHRC funds 80%). Must be team-convened with distributed co-lead leadership. Lead research organisation must have standard UKRI eligibility (UK-based). International co-leads eligible up to 30% FEC. No PhD studentships permitted. Proposals must fall within AHRC subject remit.

Health~Holland PPP programme focused on lead-212 (Pb-212) radiopharmaceuticals for cancer treatment. Two pillars: (1) Pb-212 production & supply chain; (2) enabling technologies for clinical introduction. Proposals must include a private party (not in financial difficulty) and comply with Health~Holland PPP requirements. Consortium Agreement required. Submission via KWF GMS; unregistered institutes must register ≥6 weeks before deadline.

PPP proposals for lead-212 production/supply chain or enabling technologies for clinical introduction of Pb-212 radiopharmaceuticals. Requires active private-party participation (Health~Holland PPP rules), a Consortium Agreement, and compliance with RVO 'no undertaking in difficulty' declaration. Dutch-language summary required for patient advisory review. Netherlands-based institutions; unregistered institutes must register in KWF GMS ≥6 weeks before deadline.